MA31_2: MA31, figure 2
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
MA31_2 R Documentation
MA31, figure 2
Description
Kaplan-Meier digitized data from MA31, figure 2 (PMID 25779558). A reported sample size of 652 for a primary endpoint of PFS in breast cancer.
Usage
MA31_2
Format
A data frame of 652 observations and 3 variables:
time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (ltax_l, ttax_t)
Source
Gelmon KA, Boyle FM, Kaufman B, et al. Lapatinib or Trastuzumab Plus
Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive
Advanced Breast Cancer: Final Results of NCIC CTG MA.31. J Clin Oncol
2015; 33: 1574–83.
Examples
summary(MA31_2)
kmplot(MA31_2)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| MA31_2 | R Documentation |
MA31, figure 2
Description
Kaplan-Meier digitized data from MA31, figure 2 (PMID 25779558). A reported sample size of 652 for a primary endpoint of PFS in breast cancer.
Usage
MA31_2
Format
A data frame of 652 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0: no event, 1: event) |
|
arm | treatment arms (ltax_l, ttax_t) | |
Source
Gelmon KA, Boyle FM, Kaufman B, et al. Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. J Clin Oncol 2015; 33: 1574–83.
Examples
summary(MA31_2)
kmplot(MA31_2)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.